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Transferable Multiresistance Plasmids Carrying cfr in Enterococcus spp.
from Swine and Farm Environment
Abstract
Seventy-seven porcine Enterococcus isolates with florfenicol MICs of ≥16 μg of were/ml screened for the
presence of the multiresistance gene cfr, its location on plasmids, and its genetic environment. Three
isolates—Enterococcus thailandicus 3-38 (from a porcine rectal swab collected at a pig farm), Enterococcus
thailandicus W3, and Enterococcus faecalis W9-2 (the latter two from sewage at a different farm), carried the
cfr gene. The SmaI pulsed-field gel electrophoresis patterns of the three isolates differed distinctly. In addition,
E. faecalis W9-2 was assigned to a new multilocus sequence type ST469. Mating experiments and Southern
blot analysis indicated that cfr is located on conjugative plasmids pW3 (∼75 kb) from E. thailandicus W3,
p3-38 (∼72 kb) from E. thailandicus 3-38, and pW9-2 (∼55 kb) from E. faecalis W9-2; these plasmids differed
in their sizes, additional resistance genes, and the analysis of the segments encompassing the cfr gene.
Sequence analysis revealed that all plasmids harbored a 4,447-bp central region, in which cfr was bracketed by
two copies of the novel insertion sequence ISEnfa4 located in the same orientation. The sequences flanking
the central regions of these plasmids, including the partial tra gene regions and a ω-ε-ζ toxin-antitoxin module,
exhibited >95% nucleotide sequence identity to the conjugative plasmid pAMβ1 from E. faecalis. Conjugative
plasmids carrying cfr appear to play an important role in the dissemination and maintenance of the
multiresistance gene cfr among enterococcal isolates and possibly other species of Gram-positive bacteria.
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Seventy-seven porcine Enterococcus isolates with florfenicol MICs of >16g of were/ml screened for the presence of the multire-
sistance gene cfr, its location on plasmids, and its genetic environment. Three isolates—Enterococcus thailandicus 3-38 (from a
porcine rectal swab collected at a pig farm), Enterococcus thailandicusW3, and Enterococcus faecalisW9-2 (the latter two from
sewage at a different farm), carried the cfr gene. The SmaI pulsed-field gel electrophoresis patterns of the three isolates differed
distinctly. In addition, E. faecalisW9-2 was assigned to a newmultilocus sequence type ST469. Mating experiments and South-
ern blot analysis indicated that cfr is located on conjugative plasmids pW3 (75 kb) from E. thailandicusW3, p3-38 (72 kb)
from E. thailandicus 3-38, and pW9-2 (55 kb) from E. faecalisW9-2; these plasmids differed in their sizes, additional resis-
tance genes, and the analysis of the segments encompassing the cfr gene. Sequence analysis revealed that all plasmids harbored a
4,447-bp central region, in which cfrwas bracketed by two copies of the novel insertion sequence ISEnfa4 located in the same
orientation. The sequences flanking the central regions of these plasmids, including the partial tra gene regions and a-- tox-
in-antitoxin module, exhibited>95% nucleotide sequence identity to the conjugative plasmid pAM1 from E. faecalis. Conju-
gative plasmids carrying cfr appear to play an important role in the dissemination andmaintenance of the multiresistance gene
cfr among enterococcal isolates and possibly other species of Gram-positive bacteria.
Enterococci are Gram-positive bacteria that generally colonizethe gastrointestinal tracts of animals. They are also found in
food, water, and environmental samples. Enterococci were once
considered harmless commensals of humans, but they have
emerged as important nosocomial pathogens over the past 3 de-
cades. Enterococcus spp., especially Enterococcus faecalis and En-
terococcus faecium, are now the secondmajor cause of surgical and
urinary tract infections and the third major cause of bacteremia
(1). The ability of Enterococcus spp. to acquire mobile genetic ele-
ments, such as plasmids and transposons carrying the determi-
nants of antimicrobial resistance and virulence, has contributed to
their emergence as often multiresistant pathogens. Antimicrobial
multiresistance drastically limits the therapeutic options in the
treatment of infections, and the emergence and rapid spread of
glycopeptide-resistant enterococci has presented a particular
challenge, since there are few remaining options for antimicrobial
treatment (2). As donors and recipients of antimicrobial resis-
tance genes, Enterococcus spp. play an important role in the dis-
semination of resistance genes by horizontal gene transfer. The
transmission of the vanA gene cluster-carrying transposon
Tn1546 from vancomycin-resistant enterococci (VRE) to methi-
cillin-resistant Staphylococcus aureus (MRSA), creating a vanco-
mycin- and methicillin-resistant S. aureus strain in a hospitalized
patient, represents a dramatic example of this phenomenon (3).
As the first oxazolidinone introduced for clinical use in the
United States since 2000 and in China since 2007, linezolid is
currently the most efficient antimicrobial against VRE, MRSA,
and penicillin-resistant pneumococci (4). As a last-resort antimi-
crobial agent, linezolid not only exhibits strong antibacterial ac-
tivity but also has properties that mitigate against the develop-
ment of drug resistance in bacteria (5). No evidence of a
significant increase in the percentage of linezolid-resistant bacte-
ria has been reported in the LEADER Program, whose results are
available on an annual basis since 2006 (6). Themost recent results
from the LEADER Program for the year 2009 reported an overall
percentage of linezolid resistance of 0.34% (6). Themost common
mechanism of linezolid resistance involves mutations in the cen-
tral loop of domain V of 23S rRNA, with G2576T (Escherichia coli
numbering) being the most frequent mutation (7), followed by
mutations in the genes for the ribosomal proteins L3 and L4 (8).
Transferable linezolid resistance is due to the gene cfr encoding an
rRNAmethyltransferase whichmethylates position 8 of A2503 (9)
and inhibits ribose methylation at nucleotide C2498 in the 23S
rRNA (10). Thereby, Cfr confers resistance to five chemically un-
related antimicrobial classes including phenicols, lincosamides,
oxazolidinones, pleuromutilins, and streptogramin A (11) and
decreased susceptibility to the 16-memberedmacrolides spiramy-
cin and josamycin (12).
The observation that the gene cfr is often located on plasmids
underlines the potential for the spread of this gene (11). Although
it was initially discovered on the 17.1-kb multiresistance plasmid,
pSCFS1, in a bovine Staphylococcus sciuri isolate (13), the gene cfr
has been detected in seven bacterial genera, including Staphylococ-
cus, Bacillus, Enterococcus, Macrococcus, Jeotgalicoccus, Proteus,
and Escherichia. Most of the corresponding isolates were derived
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from domestic animals (mainly pigs) (14–23), and plasmids
seemed to play an important role in the interspecies and interge-
nus transfer of the cfr gene. To date, 17 different cfr-carrying plas-
mids have been reported (Table 1). Among these plasmids, only
the staphylococcal plasmids pSCFS7 and pERGB and the entero-
coccal plasmid pHOU-cfr were characterized as conjugative plas-
mids (14, 25, 27). In the present study, we describe three transfer-
able multiresistance plasmids obtained from Enterococcus spp.
from domestic pigs and farm environments which carry the cfr
gene in new genetic environments.
MATERIALS AND METHODS
Bacterial isolates and detection of florfenicol resistance genes.A total of
77 Enterococcus isolates (E. faecalis [n 49], E. faecium [n 15], E. hirae
[n  6], E. thailandicus [n  3], E. durans [n  2], E. asini [n  1], and
Enterococcus sp. strain CIFRI D-TSB15 [n  1]) with florfenicol MIC
values of 16 g of were/ml collected from individual pigs (n  65; 57
from rectal swabs and 8 fromnasal swabs), pig farm environments (n 9;
8 from sewage and 1 from soil), and farm workers (n 3; all from rectal
swabs) in three pig farms and one slaughterhouse in Shandong province
in 2011. Although no clinical breakpoints for florfenicol applicable to
enterococci are currently available, isolates with an MIC of 16 g of
were/ml tentatively considered as florfenicol resistant. Whole-cell DNA
from the Enterococcus isolates was extracted using a commercial kit (Tian-
Gen, Beijing, China) according to the manufacturer’s instructions. The
presence of the florfenicol resistance genes cfr, fexA, and fexB was investi-
gated using previously described methods (28, 30).
Molecular typing. Pulsed-field gel electrophoresis (PFGE) was per-
formed to investigate the clonality of the cfr-positive enterococcus iso-
lates. DNA preparation and subsequent restriction analysis were con-
ducted as described previously (31). Whole-cell DNA was incubated with
SmaI (TaKaRa, Dalian, China) for 6 h at 30°C. The resulting restriction
fragments were separated using a CHEF-DRIII system (Bio-Rad) with a
clamped homogeneous electric field of 6 V/cm, using a 120° switch angle
for 16 h at 14°C, with the pulse time linearly ramped from 1 s to 20 s. The
cfr-positive bovine E. faecalis isolate EF-01, which was the first Enterococ-
cus isolate of animal origin carrying the cfr gene (17), was included for
comparison. In addition, typing of the cfr-positive E. faecalis isolates was
performed by multilocus sequence typing (MLST), using an established
set of MLST primers described previously (32).
Filter mating. Filter mating was performed with each of the three
cfr-positive original isolates using E. faecalis JH2-2 (rifampin resistance)
as the recipient, following the method described previously (33). The
concentrations of antibiotics in brain heart infusion agar plates used for
the selection of transconjugants were 25g/ml for rifampin and 10g/ml
for florfenicol. Transconjugants were confirmed as cfr positive and fexA
and fexB negative by PCR analysis; PFGE was also performed in all
transconjugants using SmaI to confirm that they were derivatives of the
recipient strain JH2-2.
Antimicrobial susceptibility testing. The MICs of all of the cfr-posi-
tive original Enterococcus isolates, transconjugants, and E. faecalis JH2-2
were determined using broth microdilution according to the recommen-
dations of documents M31-A3 (34) and M100-S21 (35) of the Clinical
and Laboratory Standards Institute. The reference strain E. faecalisATCC
29212 served as a quality control.
Analysis of cfr-carrying plasmids. To estimate the size of the cfr-
carrying plasmids, whole-cell DNA of the enterococcal isolates in agarose
gel plugs were treated with S1 nuclease (TaKaRa) and then separated by
PFGE as described previously (36, 37); gels were run for 14 h. Plasmid
DNA was extracted using a plasmid extraction midi kit (Qiagen, Ger-
many) using amodification described previously (17). The extracted plas-
mids and S1 nuclease-linearized PFGE-separated plasmid DNA frag-
ments were transferred to Hybond N membranes (Amersham
Biosciences, USA) and hybridized with digoxigenin (DIG)-labeled cfr-,
fexA-, or fexB-specific probes. The DIG High Prime DNA Labeling and
Detection Starter Kit I (Roche Applied Sciences, Germany) was used for
detection. The regions flanking the cfr gene were sequenced by amodified
randomprimer sequencingwalking strategy, as previously described (38).
To determine the stability of the ISEnfa4 flanked segments in plasmids in
both the original strains and in the transconjugants, inverse PCR was
performed using the primers cfrIF and cfrIR (these are complementary to
locations inside the cfr gene) (22).
Nucleotide sequence accession numbers. The nucleotide sequences
of a 27,360-bp segment of plasmid pW3, a 21,116-bp fragment of p3-38,
and a 25,761-bp segment of pW9-2 have been deposited in GenBank
under accession numbers JQ911739 (pW3), JQ911740 (p3-38), and
JQ911741 (pW9-2), respectively.
RESULTS
Identification of the florfenicol resistance genes cfr, fexA, and
fexB in Enterococcus isolates. PCR analysis of whole-cell DNA
with primers specific for the three florfenicol resistance genes—
cfr, fexA, and fexB—thus far identified in Enterococcus demon-
strated that these genes were present alone or in different combi-
nations inmost of the isolates included in the present study.Of the
77 enterococci studied, 68 isolates carried either fexA (n  36),
fexB (n 14), or both genes (n 18); only two isolates (E. thai-
landicus 3-38 and E. faecalis W9-2) carried both cfr and fexA,
whereas only one isolate (E. thailandicusW3) carried both cfr and
fexB. Interestingly, six isolates did not harbor any of these genes.
Of the three cfr-positive isolates, E. thailandicus 3-38 was collected
from a rectal swab of a pig, whereas E. thailandicus W3 and E.
faecalis W9-2 were collected from sewage at a different pig farm.
The nucleotide sequences of the amplified cfr genes in these three
strains were 100% identical to the cfr gene of the S. sciuri plasmid
pSCFS1 (accession number NC_005076). The 977-bp fexA ampli-
con from E. faecalisW9-2 was identical to the corresponding fexA
sequence of the S. aureus plasmid pSCFS7 (FN995110), whereas a
single nucleotide exchange (T¡A) at position 551 was detected in
the fexA amplicon of E. thailandicus 3-38R, which caused an
amino acid change at position 71 of the phenicol exporter protein
TABLE 1 Overviewof the so far identified cfr-carryingplasmids in
different bacteria
Host bacteria Plasmid Size (kb) Reference
Staphylococcus spp. pSCFS1 17.1 24
pSCFS3 35.7 16
pSCFS6 43 24
pSCFS7 45 25
p004-737X 55 26
p426-3147L 175 26
pSS-01 40 22
pSS-02 35.4 22
pSS-03 7.1 22
pERGB 50 27
Bacillus spp. pBS-01 16.5 28
pBS-02 16.5 23
pBS-03 7.4 19
Jeotgalicoccus andMacrococcus spp. pJP1 53 21
E. faecalis pEF-01 32.4 17
pHOU-cfr 97 14
E. coli pEC-01 110 29
Conjugative Plasmids Carrying cfr in Enterococci
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(Phe¡Ile). Finally, the 786-bp fexB amplicon obtained from E.
thailandicus W3 was identical to fexB from plasmid pEFM-1
(JN201336) of E. faecium.
Antimicrobial resistance, clonality, and plasmid profiles of
the cfr-positive enterococci isolates.All three cfr-positive isolates
exhibited resistance to chloramphenicol, erythromycin, tetracy-
cline, ciprofloxacin, and rifampin and had elevated MICs against
florfenicol (up to 64 to 128 g/ml) but were susceptible to ampi-
cillin and vancomycin. In addition, the MICs for linezolid were 8
g/ml (E. thailandicus 3-38) and 4g/ml (E. thailandicusW3 and
E. faecalisW9-2) (Table 2). PFGE analysis of the four cfr-positive
Enterococcus isolates, including the previously described bovine
cfr-carrying E. faecalis isolate EF-01, revealed marked genomic
heterogeneity of less than 65% similarity in their SmaI patterns
(Fig. 1A). MLST of E. faecalis EF-01 indicated that it belongs to
ST21 within the clonal complex 21 (CC21) (39), whereas E. faeca-
lisW9-2 represented the novel ST type ST469.
Conjugation proved successful using isolates W3, 3-38, and
W9-2 as the donor strains and JH2-2 as the recipient strain; three
transconjugants, designated JHW3, JH3-38 and JHW9-2, respec-
tively, were obtained. The sizes of the plasmids present in the
original strains and their transconjugants were determined by S1
nuclease-PFGE. Each of the original strains harbored at least three
plasmids, but at least one visible plasmid band could be observed
in each of the three transconjugants (Fig. 1B). Southern blot anal-
ysis showed that the cfr probe hybridized to a band of 75 kb in
both W3 and JHW3, a band of72 kb in both 3-38 and JH3-38,
and a band of55 kb in both W9-2 and JHW9-2 (Fig. 1C); these
three cfr-carrying plasmids were designated pW3, p3-38 and
pW9-2, respectively. In addition, we confirmed that the florfeni-
col exporter gene fexAwas not associated with any of the plasmids
in E. thailandicus 3-28 and located on an 40-kb plasmid in E.
faecalisW9-2, while the fexB gene was located on an50-kb plas-
mid in E. thailandicusW3 (data not shown).
MIC testing revealed that all transconjugants exhibited at least
4-fold-elevated MICs for chloramphenicol, florfenicol, and lin-
ezolid compared to the recipient JH2-2 strain. No observableMIC
changes were found for tetracycline and ciprofloxacin. Interest-
ingly, all transconjugants showed 32-fold elevatedMICs for eryth-
romycin, compared to JH2-2 (Table 2). PCR screening to detect
erythromycin resistance genes using previously described primers
(40, 41) revealed the presence of the erm(B) gene in transconju-
gants JHW3 and JHW9-2 and their original strains, while the
erm(A) gene was detected in both JH3-38 and 3-38. The erm(B)
gene in pW3 and pW9-2 encode a 245-amino-acid (aa) rRNA
methylase that shares 100% identity with Erm(B) from Streptococ-
cus suis D12 (AER19841), and the Erm(B) protein differs by only
four aa exchanges (S100N,H163Y,H217Y, andN222D) from that
from pAM1 (ACY79534). The 571-bp erm(A) amplicon from
TABLE 2 Antimicrobial susceptibility profiles of cfr-positive enterococci
isolates W3, 3-38, and W9-2 and their transconjugants JHW3, JH3-38
and JHW9-2, for which E. faecalis JH2-2 served as recipient strain
Isolate Organism Origin
MIC(g/ml)a
CHL FFC LIZ ERY TET AMP VAN CIP
W3 E. thailandicus Sewage 64 64 4 128 128 1 1 8
3-38 E. thailandicus Swine 64 64 8 128 128 4 1 8
W9-2 E. faecalis Sewage 64 128 4 128 128 1 1 8
JH2-2 E. faecalis NAb 8 8 2 0.25 2 1 1 2
JHW3 E. faecalis NA 32 32 8 8 2 1 1 2
JH3-38 E. faecalis NA 32 32 8 8 2 1 1 2
JHW9-2 E. faecalis NA 32 32 8 8 2 1 1 2
a CHL, chloramphenicol; FFC, florfenicol; LIZ, linezolid; ERY, erythromycin; TET,
tetracycline; AMP, ampicillin; VAN, vancomycin; CIP, ciprofloxacin.
b NA, not applicable.
FIG 1 (A) SmaI-PFGE patterns from E. faecalis EF-01 and three cfr-positive isolates used in the present study. Lanes 1 to 4, E. faecalis EF-01, E. thailandicusW3,
E. thailandicus 3-38, and E. faecalis W9-2, respectively; lanes M1 contain the XbaI pattern of Salmonella braenderup H9812 with the fragment sizes given in
kilobases on the right-hand side. (B) Numbers and sizes of plasmids as determined by S1 nuclease PFGE. LaneM2, low-range PFGmarker (NEB); lanes 5 and 5=,
W3R and its transconjugant JHW3; lanes 6 and 6=, 3-38 and its transconjugant JH3-38; lanes 7 and 7=, W9-2 and its transconjugant JHW9-2; lane 8, the recipient
E. faecalis JH2-2. (C) Southern hybridization with the cfr probe. The lane numbers correspond to those in panel B.
Liu et al.
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both 3-38 and JH3-38 was identical to the corresponding erm(A)
sequence of the Streptococcus suis isolate B1 (EU047809).
Analysis of the genetic environment of cfr in the conjugative
plasmids pW3, p3-38, and pW9-2. To gain insight into the ge-
netic environment of the cfr gene in the three newly identified
conjugative plasmids, cfr-carrying segments of 27,360, 21,116, and
25,550 bp of the 75-kb plasmid pW3, the 72-kb plasmid p3-
38, and the55-kb pW9-2 plasmid, respectively, were sequenced.
The corresponding maps are shown in Fig. 2.
All three segments had an overall nucleotide sequence identity
of96% with respect to each other. The 4,447-bp central region,
including cfr and the two 1,324-bp insertion sequences located in
the same orientation, even displayed 100% nucleotide sequence
identity. The further flanking sequences in pW3, p3-38, and
pW9-2 exhibited a high nucleotide sequence identity (95%) to
the corresponding regions of the conjugative plasmid pAM1
(GU128949) from E. faecalis (Fig. 2).
In the cfr upstream region, the putative promoter and the
partly overlapping reading frames for peptides of 59 aa (ORF1)
and 44 aa (ORF2) were present. However, in comparison to
pSCFS1, a 51-bp deletion had occurred inORF1which resulted in
the loss of the first 17 aa of ORF1. This deletion was also present in
the cfr upstream region of pEF-01 from bovine E. faecalis (17) but
differed from the 35-bp deletion in the region between the stop
codon of ORF2 and the start codon of cfr in the staphylococcal
plasmid pSCFS3 (16). Two copies of a 1,324-bp insertion se-
quence harboring a 1,173-bp transposase gene and imperfect
26-bp terminal inverted repeats were found. These insertion se-
quences aremost closely related to IS1542 from E. faeciumwith an
overall nucleotide sequence identity of 91.6% (1,213/1,324 bp)
and 93.8% aa sequence identity (366/390 aa) in the transposase
protein (42). This insertion sequence was submitted to the IS da-
tabase (http://www-is.biotoul.fr/is.html) and received the desig-
nation ISEnfa4. Except for an 823-bp sequence, including the orf1
located downstream of the cfr gene on pSS-01, the 4,447-bp cen-
tral region shared99%nucleotide identity with the correspond-
ing region of plasmid pSS-01 (accession no. JQ041372) present in
S. cohnii and S. saprophyticus (Fig. 3).
Immediately upstream of the righthand ISEnfa4 element and
downstreamof the left-hand ISEnfa4 element in the 4,447-bp cen-
tral region, two different 8-bp direct repeats (DR) at the integra-
tion site were observed in the three conjugative plasmids. One DR
(5=-TAGAATCA-3=), located in the open reading frame of AM16
(which exhibited 99% nucleotide [304/306 bp] identity to that
in pAM1), was found in the E. faecalis plasmid pW9-2. The other
DR (5=-GAAATTGA-3=), located in a noncoding region between
the genes AM15 and AM17, was found in both E. thailandicus
plasmids pW3-1 andp3-38. It should be noted that theAM16 gene
could not be detected in these two plasmids (Fig. 3). To determine
the stability of the ISEnfa4 flanked segment in the three conjuga-
tive plasmids, inverse PCR assays were performed using cfrIF and
cfrIR primers. Amplicons 3,123 bp in size were obtained from
each of the three parental strains and their transconjugants. Se-
quence analysis of these amplicons confirmed that they contained
an intact cfr gene region and one complete ISEnfa4 element.
DISCUSSION
Since only little a information is currently available about the
presence of the multiresistance gene cfr among enterococci of an-
imal origin (17), we screened 77 enterococcal isolates for the pres-
ence of this gene. The detection of the cfr gene in 3 of 77 (3.9%)
florfenicol-resistant enterococcus strains of swine and farm envi-
ronmental origin suggested that this multiresistance gene is rela-
tively rare among enterococci from pig farms in Shandong Prov-
ince, China. To the best of our knowledge, this is the first report of
the cfr gene in the species E. thailandicus. E. thailandicus is a newly
discovered enterococcal species, which was initially isolated from
fermented sausage in Thailand (43). To date, no clinical E. thai-
landicus isolate has been reported; however, two strains of Entero-
coccus sanguinicola, which in the meantime have been reclassified
as E. thailandicus, were recovered from clinically relevant human
sources (44). The presence of the cfr gene in E. thailandicus from
swine and sewage origins points toward the presence of this mul-
tiresistance gene in enterococci from animal settings and the sur-
rounding environment.
The predominant resistance gene among florfenicol-resistant
enterococci was fexA, which was detected in 72.7% (56/77) of the
isolates tested in the present study; this finding was similar to the
FIG 2 Genetic environment of cfr gene in the conjugative plasmids p3-38, pW3, and pW9-2 and structural comparison with the conjugative plasmid pAM1
from E. faecalis strain DS5. Regions of95% homology are marked by gray shading.
Conjugative Plasmids Carrying cfr in Enterococci
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percentage of fexA-positive isolates among florfenicol-resistant
staphylococci of swine origin (73.2%, 109/149) (22). In addition,
the recently identified florfenicol exporter gene fexB was detected
in 41.6% (32/77) of the isolates tested in the present study. The
coexistence of fexA and fexB in the same isolate was also observed
in 18 (23.4%) of the strains tested. In addition, 7.8% (6/77) of the
florfenicol-resistant isolates examined here did not harbor any of
the three genes cfr, fexA, or fexB, which suggests that potential
nonenzymatic or enzymatic mechanisms conferred by other, as-
yet-identified resistance genes might be involved in florfenicol
resistance in enterococci.
The different SmaI PFGE patterns observed suggested that the
three porcine and the single bovine cfr-positive enterococcal iso-
lates are not related. Furthermore, MLST of two cfr-carrying E.
faecalis strains originating from swine and cattle in China revealed
that one of these isolates (EF-01) belongs to ST21, and the other
(W9-2) represents the novel type ST469. The E. faecalis EF-01
isolate, which belonged to the clonal complex CC21, is mainly
found in animals and in the community, while clinical isolates of
this CC have rarely been detected (45). Concerning theW9-2 iso-
lates, the ST469 belongs to a singleton, which did not have single
or double locus variants by performing an eBURST analysis (data
not shown).
In the present study, three different types of large cfr-carrying
conjugative enterococcal plasmids—pW3, p3-38, and pW9-2—
could be differentiated on the basis of their sizes, their additional
erythromycin resistance genes, and the sequences surrounding the
cfr gene. Despite these differences, high structural similarities be-
tween these three plasmids and plasmid pAM1 were observed.
Plasmid pAM1, a member of a family of low-copy-number con-
jugative plasmids (46), was originally identified in a E. faecalisDS5
clinical isolate that harbored the MLSB resistance gene erm(B)
(47) and could be transferred to, and maintained in, a wide range
of Gram-positive bacteria (e.g., enterococci, streptococci, S. au-
reus,Bacillus subtilis, and some Lactobacillus casei strains), indicat-
ing a broad host range (48). In the present study, the MLSB resis-
tance genes erm(A) and erm(B), the partial nucleotide sequence of
the tra gene regions, and an -ε- toxin-antitoxin module were
observed in all three partially sequenced conjugative plasmids.
This suggested that the 4,447-bp central region with the cfr gene
and two ISEnfa4 elements had integrated into a pAM1-like back-
bone. A closer look at the sequences identified two integration
sites. We propose that the 4,447-bp central region in pW9-2 has
integrated into the coding sequence of AM16 via sample transpo-
sition; while in pW3 and p3-38, this element probably integrated
into the region between theAM15 andAM17 genes, most likely by
homologous recombination. The PCR-based stability tests also
revealed that the cfr gene and one ISEnfa4 copy can easily be ex-
cised, suggesting that this multiresistance gene may also be trans-
ferable via ISEnfa4-mediated recombination.
With the exception of the multiresistance gene cfr, the MLSB
genes erm(A) or erm(B) have also been found in three conjugative
plasmids in our study. The coexistence of MLSB genes and cfr in
the same plasmid will allow for persistence and coselection of the
cfr gene under the positive selective pressure imposed by the use of
macrolides, such as tylosin and tilmicosin. Themacrolides, as well
as a number of other classes of antimicrobials, including ampicil-
lin, florfenicol, trimethoprim-sulfamethoxazole, lincomycin, and
tiamulin, have been used for curing or preventing bacterial infec-
tions in three of the pig farms investigated here, according to the
antibiotic usage records of these farms. The persistence of the
cfr-carrying plasmids among enterococci identified here may also
be attributed to the coexistence of -ε- toxin-antitoxin module,
which is known to promote the persistence of plasmids by encod-
FIG 3 Schematic presentation of detailed genetic environment of the cfr gene in 4,447-bp center regions in conjugative plasmids pW9-2, pW3, and p3-38 and
structure comparisonwith plasmid pHOU-cfr fromE. faecalis 603-50427Xof clinical humanorigin andpSS-01 from S. cohniiof swine origin. The arrows indicate
the positions and direction of the transcription of the genes. The regions of96% homology are marked using gray shading. The direct target site duplication
is boxed. 	, Truncated gene. A distance scale in kilobases is displayed in the upper right corner.
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ing a system that kills or prevents the growth of plasmid-free cells
(49). Therefore, the potential threat that the accumulation ofmul-
tiple resistance genes including cfr on a plasmid with a toxin-
antitoxin module poses is of great concern.
In conclusion, the data presented here described three conju-
gative plasmids carrying the multiresistance gene cfr in entero-
cocci from pigs and their surrounding environments. The cfr-
carrying center region flanked by the ISEnfa4 elements in these
conjugative plasmids harboring tra regions and toxin-antitoxin
systems is a potential risk factor for dissemination of this multire-
sistance gene among enterococci isolates and possibly other spe-
cies of Gram-positive bacteria, which many believe cause a threat
to public health.
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